Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Prudential PLC (PUK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Prudential PLC — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while Prudential PLC trades at $24.01 (market cap $29.25B). The key difference: Prudential PLC is far larger — about 4.1× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Prudential PLC pays a 2.33% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Prudential PLC for 119 Days on average.
| IONS | PUK | |
|---|---|---|
Market Cap | $7.10B | $29.25B |
Volume | 2,027,457 | 1,214,779 |
Sector | Health | Financials |
52-Week High | $86.50 | $33.61 |
52-Week Low | $42.38 | $23.54 |
Typical Hold Time | 0 Days | 119 Days |
Enterprise Value | $6.66B | $28.79B |
Dividend Yield | — | 2.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Prudential Public Limited Company (PUK) trades at $23.83, down 0.17% on the day. The stock shows mixed technical signals with a bearish moving average trend but oversold RSI levels. Fundamentally, the company reported strong revenue growth to $27.39 billion in 2025 and a net income margin of 12.27%, though recent quarterly EPS results were mixed with two beats and two misses. Analyst sentiment is moderately positive with a 50% buy rating.
PUK presents a value opportunity with a low P/E of 8.37 and solid profitability, but faces risks from inconsistent earnings performance and a bearish technical outlook. The company's strategic focus on core markets and capital efficiency initiatives supports long-term growth, though near-term volatility may persist.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Prudential PLC
Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →
